A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

Condition:   Gout Interventions:   Drug: Epaminurad 6 mg;   Drug: Epaminurad 9 mg;   Drug: Febuxostat 40 mg;   Drug: Febuxostat 80 mg;   Drug: Epaminurad 6 mg placebo;   Drug: Epaminurad 9 mg placebo;   Drug: Febuxostat 40 mg placebo;   Drug: Febuxostat 80 mg placebo Sponsor:   JW Pharmaceutical Recruiting

Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials